Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Geoffrey Brooke Insider Profile
4 Followers
Geoffrey Brooke, Director at Cynata Therapeutics Limited, holds 1.98M shares in Acrux Limited (Ticker: ARUXF), holds 312.90K shares in Cynata Therapeutics Limited (Ticker: CYYNF). Most recently, Geoffrey Brooke Bought ― shares of Acrux Limited on Feb 13, 2025 for an estimated value of 10.00K.
Geoffrey Brooke Cynata Therapeutics Limited (CYYNF)Director
Cynata Therapeutics Limited (CYYNF)
Director
Ranked #87,597 out of 100,516 Corporate Insiders
Profitable Transactions
1 out of 6 Profitable Transactions
Average Return
-28.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Geoffrey Brooke holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 24, 2020 - Jun 24, 2021
Return:+3.70%
The most profitable trade made by Geoffrey Brooke
Geoffrey Brooke's Trading History
Cynata Therapeutics Limited
Jan 23, 2025
Director
Informative Buy
10.00K
$43.18K
Acrux Limited
Feb 13, 2025
Director
Informative Buy
10.00K
$59.28K
List of latest transactions for each holding click on a transaction to see Geoffrey Brooke's performance on stock
You May Also Like
Geoffrey Brooke insider profile FAQ
What is the percentage of profitable transactions made by Geoffrey Brooke?
The percentage of profitable transactions made by Geoffrey Brooke is 17%.
What is the average return per transaction made by Geoffrey Brooke?
The average return per transaction made by Geoffrey Brooke is -28.40%.
What stocks does Geoffrey Brooke hold?
Geoffrey Brooke holds: CYYNF, ARUXF stocks.
What was Geoffrey Brooke’s latest transaction?
Geoffrey Brooke latest transaction was an Informative Buy of $10.00K.
What was Geoffrey Brooke's most profitable transaction?
Geoffrey Brooke’s most profitable transaction was an Informative Buy of CYYNF stock on June 24, 2020. The return on the trade was 3.70%.
What is Geoffrey Brooke's role in Cynata Therapeutics Limited?
Geoffrey Brooke's role in Cynata Therapeutics Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.